PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hematology Service, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.\', \'Divison of Infectious Diseases, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.\', \'Hematology Service, Hospital Universitario Fundación Jiménez-Díaz, Madrid, Spain.\', \'Internal Medicine Department, Clínica Universidad de Navarra, Madrid, Spain.\', \'CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.\', \'Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.\', \'Internal Medicine Department, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain.\', \'Hematology Service, Hospital Universitario La Paz, Madrid, Spain.\', \'Clinical Trials Unit, Clínica Universidad de Navarra, Pamplona, Spain.\', \'Internal Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain.\', \'CIBER Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1055/a-1667-7534
?:doi
?:hasPublicationType
?:journal
  • Thrombosis and haemostasis
is ?:pmid of
?:pmid
?:pmid
  • 34638151
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.074
?:rankingScore_hIndex
  • 176
is ?:relation_isRelatedTo_publication of
?:title
  • Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all